Hepatitis B, Hepatitis C, Hepatobiliary Cancers, Hepatobiliary Cancers Liver, Liver Cancer
Conditions
Brief summary
Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV genome in patients with chronic HBV infection, and in patients with liver cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV genome that predisposes these high risk individuals to the development of liver cancer.
Interventions
None listed
Sponsors
Stanford University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patients diagnosed with liver cancer based on biopsy or serum AFP level, associated with characteristic hypervascular liver tumors on triphasic spiral CT scan or MRI. 2\. Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or nodular hyperplasia. 3\. Patients with hepatitis B or hepatitis C viral infections not associated with liver cancer.
Exclusion criteria
No other patients except those listed above will be recruited. Additionally, patients will be excluded if, upon looking through their medical records, information required for data analysis are missing.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| identify mutations in the hepatitis B virus genome that predisposes these high risk individuals to the development of liver cancer | one time | We will be using blood specimens collected through another protocol |
Countries
United States
Outcome results
None listed